Cytotoxic	B:C0596402
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxy	O
formosum	I:C1219382
extract	O
against	O
HepG2	O
liver	O
cancer	I:C2717940
cells	I:C2717940
.	O

Cytotoxic	O
and	O
antimigratory	B:C1524058
effects	I:C1524058
of	O
Cratoxy	O
formosum	I:C1219382
extract	O
against	O
HepG2	O
liver	O
cancer	I:C2717940
cells	I:C2717940
.	O

Cytotoxic	O
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxy	B:C1219382
formosum	I:C1219382
extract	O
against	O
HepG2	O
liver	O
cancer	I:C2717940
cells	I:C2717940
.	O

Cytotoxic	O
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxy	O
formosum	I:C1219382
extract	B:C0032081
against	O
HepG2	O
liver	O
cancer	I:C2717940
cells	I:C2717940
.	O

Cytotoxic	O
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxy	O
formosum	I:C1219382
extract	O
against	O
HepG2	B:C2717940
liver	O
cancer	I:C2717940
cells	I:C2717940
.	O

Cytotoxic	O
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxy	O
formosum	I:C1219382
extract	O
against	O
HepG2	O
liver	B:C2717940
cancer	I:C2717940
cells	I:C2717940
.	O

The	O
aim	O
of	O
the	O
present	O
study	B:C2603343
was	O
to	O
investigate	O
the	O
molecular	O
mechanisms	I:C1148560
underlying	O
Cratoxylum	O
formosum	I:C1219382
(	O
Cratoxylum	O
formosum	I:C1219382
)	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
molecular	B:C1148560
mechanisms	I:C1148560
underlying	O
Cratoxylum	O
formosum	I:C1219382
(	O
Cratoxylum	O
formosum	I:C1219382
)	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
molecular	O
mechanisms	I:C1148560
underlying	O
Cratoxylum	B:C1219382
formosum	I:C1219382
(	O
Cratoxylum	O
formosum	I:C1219382
)	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
molecular	O
mechanisms	I:C1148560
underlying	O
Cratoxylum	O
formosum	I:C1219382
(	O
Cratoxylum	B:C1219382
formosum	I:C1219382
)	O

Dyer	O
-	O
induced	O
cancer	B:C0006826
cell	O
death	I:C0007587
and	O
antimigratory	O
effects	I:C1524058
in	O
HepG2	O
liver	O
cancer	I:C2717940
cells	I:C2717940
.	O

Dyer	O
-	O
induced	O
cancer	O
cell	B:C0007587
death	I:C0007587
and	O
antimigratory	O
effects	I:C1524058
in	O
HepG2	O
liver	O
cancer	I:C2717940
cells	I:C2717940
.	O

Dyer	O
-	O
induced	O
cancer	O
cell	O
death	I:C0007587
and	O
antimigratory	B:C1524058
effects	I:C1524058
in	O
HepG2	O
liver	O
cancer	I:C2717940
cells	I:C2717940
.	O

Dyer	O
-	O
induced	O
cancer	O
cell	O
death	I:C0007587
and	O
antimigratory	O
effects	I:C1524058
in	O
HepG2	B:C2717940
liver	O
cancer	I:C2717940
cells	I:C2717940
.	O

Dyer	O
-	O
induced	O
cancer	O
cell	O
death	I:C0007587
and	O
antimigratory	O
effects	I:C1524058
in	O
HepG2	O
liver	B:C2717940
cancer	I:C2717940
cells	I:C2717940
.	O

The	O
cytotoxic	B:C0596402
,	O
antiproliferative	O
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxylum	O
formosum	I:C1219382
leaf	O
extract	I:C0032081
on	O
human	O
liver	O
cancer	I:C0345904
HepG2	O
cell	I:C2717940
lines	I:C2717940
were	O
evaluated	O
using	O
sulforhodamine	O
B	I:C0065078
,	O
colony	O
formation	I:C0009385
,	O
and	O
wound	O
healing	I:C0005507
assays	I:C0005507
.	O

The	O
cytotoxic	O
,	O
antiproliferative	B:C1156236
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxylum	O
formosum	I:C1219382
leaf	O
extract	I:C0032081
on	O
human	O
liver	O
cancer	I:C0345904
HepG2	O
cell	I:C2717940
lines	I:C2717940
were	O
evaluated	O
using	O
sulforhodamine	O
B	I:C0065078
,	O
colony	O
formation	I:C0009385
,	O
and	O
wound	O
healing	I:C0005507
assays	I:C0005507
.	O

The	O
cytotoxic	O
,	O
antiproliferative	O
and	O
antimigratory	B:C1524058
effects	I:C1524058
of	O
Cratoxylum	O
formosum	I:C1219382
leaf	O
extract	I:C0032081
on	O
human	O
liver	O
cancer	I:C0345904
HepG2	O
cell	I:C2717940
lines	I:C2717940
were	O
evaluated	O
using	O
sulforhodamine	O
B	I:C0065078
,	O
colony	O
formation	I:C0009385
,	O
and	O
wound	O
healing	I:C0005507
assays	I:C0005507
.	O

The	O
cytotoxic	O
,	O
antiproliferative	O
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxylum	B:C1219382
formosum	I:C1219382
leaf	O
extract	I:C0032081
on	O
human	O
liver	O
cancer	I:C0345904
HepG2	O
cell	I:C2717940
lines	I:C2717940
were	O
evaluated	O
using	O
sulforhodamine	O
B	I:C0065078
,	O
colony	O
formation	I:C0009385
,	O
and	O
wound	O
healing	I:C0005507
assays	I:C0005507
.	O

The	O
cytotoxic	O
,	O
antiproliferative	O
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxylum	O
formosum	I:C1219382
leaf	B:C0032081
extract	I:C0032081
on	O
human	O
liver	O
cancer	I:C0345904
HepG2	O
cell	I:C2717940
lines	I:C2717940
were	O
evaluated	O
using	O
sulforhodamine	O
B	I:C0065078
,	O
colony	O
formation	I:C0009385
,	O
and	O
wound	O
healing	I:C0005507
assays	I:C0005507
.	O

The	O
cytotoxic	O
,	O
antiproliferative	O
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxylum	O
formosum	I:C1219382
leaf	O
extract	I:C0032081
on	O
human	B:C0086418
liver	O
cancer	I:C0345904
HepG2	O
cell	I:C2717940
lines	I:C2717940
were	O
evaluated	O
using	O
sulforhodamine	O
B	I:C0065078
,	O
colony	O
formation	I:C0009385
,	O
and	O
wound	O
healing	I:C0005507
assays	I:C0005507
.	O

The	O
cytotoxic	O
,	O
antiproliferative	O
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxylum	O
formosum	I:C1219382
leaf	O
extract	I:C0032081
on	O
human	O
liver	B:C0345904
cancer	I:C0345904
HepG2	O
cell	I:C2717940
lines	I:C2717940
were	O
evaluated	O
using	O
sulforhodamine	O
B	I:C0065078
,	O
colony	O
formation	I:C0009385
,	O
and	O
wound	O
healing	I:C0005507
assays	I:C0005507
.	O

The	O
cytotoxic	O
,	O
antiproliferative	O
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxylum	O
formosum	I:C1219382
leaf	O
extract	I:C0032081
on	O
human	O
liver	O
cancer	I:C0345904
HepG2	B:C2717940
cell	I:C2717940
lines	I:C2717940
were	O
evaluated	O
using	O
sulforhodamine	O
B	I:C0065078
,	O
colony	O
formation	I:C0009385
,	O
and	O
wound	O
healing	I:C0005507
assays	I:C0005507
.	O

The	O
cytotoxic	O
,	O
antiproliferative	O
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxylum	O
formosum	I:C1219382
leaf	O
extract	I:C0032081
on	O
human	O
liver	O
cancer	I:C0345904
HepG2	O
cell	I:C2717940
lines	I:C2717940
were	O
evaluated	O
using	O
sulforhodamine	B:C0065078
B	I:C0065078
,	O
colony	O
formation	I:C0009385
,	O
and	O
wound	O
healing	I:C0005507
assays	I:C0005507
.	O

The	O
cytotoxic	O
,	O
antiproliferative	O
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxylum	O
formosum	I:C1219382
leaf	O
extract	I:C0032081
on	O
human	O
liver	O
cancer	I:C0345904
HepG2	O
cell	I:C2717940
lines	I:C2717940
were	O
evaluated	O
using	O
sulforhodamine	O
B	I:C0065078
,	O
colony	B:C0009385
formation	I:C0009385
,	O
and	O
wound	O
healing	I:C0005507
assays	I:C0005507
.	O

The	O
cytotoxic	O
,	O
antiproliferative	O
and	O
antimigratory	O
effects	I:C1524058
of	O
Cratoxylum	O
formosum	I:C1219382
leaf	O
extract	I:C0032081
on	O
human	O
liver	O
cancer	I:C0345904
HepG2	O
cell	I:C2717940
lines	I:C2717940
were	O
evaluated	O
using	O
sulforhodamine	O
B	I:C0065078
,	O
colony	O
formation	I:C0009385
,	O
and	O
wound	B:C0005507
healing	I:C0005507
assays	I:C0005507
.	O

In	O
addition	O
,	O
apoptosis	B:C0162638
induction	O
mechanisms	I:C1148560
were	O
investigated	O
via	O
reactive	O
oxygen	I:C1148560
species	I:C1148560
(	I:C1148560
ROS	I:C1148560
)	I:C1148560
formation	I:C1148560
,	O
caspase	O
3	I:C1150132
activities	I:C1150132
,	O
and	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
(	O
ΔΨm	O
)	O
disruption	O
.	O

In	O
addition	O
,	O
apoptosis	O
induction	B:C1148560
mechanisms	I:C1148560
were	O
investigated	O
via	O
reactive	O
oxygen	I:C1148560
species	I:C1148560
(	I:C1148560
ROS	I:C1148560
)	I:C1148560
formation	I:C1148560
,	O
caspase	O
3	I:C1150132
activities	I:C1150132
,	O
and	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
(	O
ΔΨm	O
)	O
disruption	O
.	O

In	O
addition	O
,	O
apoptosis	O
induction	O
mechanisms	I:C1148560
were	O
investigated	O
via	O
reactive	B:C1148560
oxygen	I:C1148560
species	I:C1148560
(	I:C1148560
ROS	I:C1148560
)	I:C1148560
formation	I:C1148560
,	O
caspase	O
3	I:C1150132
activities	I:C1150132
,	O
and	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
(	O
ΔΨm	O
)	O
disruption	O
.	O

In	O
addition	O
,	O
apoptosis	O
induction	O
mechanisms	I:C1148560
were	O
investigated	O
via	O
reactive	O
oxygen	I:C1148560
species	I:C1148560
(	I:C1148560
ROS	I:C1148560
)	I:C1148560
formation	I:C1148560
,	O
caspase	B:C1150132
3	I:C1150132
activities	I:C1150132
,	O
and	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
(	O
ΔΨm	O
)	O
disruption	O
.	O

In	O
addition	O
,	O
apoptosis	O
induction	O
mechanisms	I:C1148560
were	O
investigated	O
via	O
reactive	O
oxygen	I:C1148560
species	I:C1148560
(	I:C1148560
ROS	I:C1148560
)	I:C1148560
formation	I:C1148560
,	O
caspase	O
3	I:C1150132
activities	I:C1150132
,	O
and	O
mitochondrial	B:C1720920
membrane	I:C1720920
potential	I:C1720920
(	O
ΔΨm	O
)	O
disruption	O
.	O

In	O
addition	O
,	O
apoptosis	O
induction	O
mechanisms	I:C1148560
were	O
investigated	O
via	O
reactive	O
oxygen	I:C1148560
species	I:C1148560
(	I:C1148560
ROS	I:C1148560
)	I:C1148560
formation	I:C1148560
,	O
caspase	O
3	I:C1150132
activities	I:C1150132
,	O
and	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
(	O
ΔΨm	B:C1720920
)	O
disruption	O
.	O

Gene	B:C0017262
expression	I:C0017262
and	O
apoptosis	O
-	I:C0033684
associated	I:C0033684
protein	I:C0033684
levels	O
were	O
measured	O
by	O
reverse	O
transcription	I:C0599161
-	I:C0599161
quantitative	I:C0599161
polymerase	I:C0599161
chain	I:C0599161
reaction	I:C0599161
and	O
western	O
blotting	I:C0005863
.	O

Gene	O
expression	I:C0017262
and	O
apoptosis	B:C0033684
-	I:C0033684
associated	I:C0033684
protein	I:C0033684
levels	O
were	O
measured	O
by	O
reverse	O
transcription	I:C0599161
-	I:C0599161
quantitative	I:C0599161
polymerase	I:C0599161
chain	I:C0599161
reaction	I:C0599161
and	O
western	O
blotting	I:C0005863
.	O

Gene	O
expression	I:C0017262
and	O
apoptosis	O
-	I:C0033684
associated	I:C0033684
protein	I:C0033684
levels	O
were	O
measured	O
by	O
reverse	B:C0599161
transcription	I:C0599161
-	I:C0599161
quantitative	I:C0599161
polymerase	I:C0599161
chain	I:C0599161
reaction	I:C0599161
and	O
western	O
blotting	I:C0005863
.	O

Gene	O
expression	I:C0017262
and	O
apoptosis	O
-	I:C0033684
associated	I:C0033684
protein	I:C0033684
levels	O
were	O
measured	O
by	O
reverse	O
transcription	I:C0599161
-	I:C0599161
quantitative	I:C0599161
polymerase	I:C0599161
chain	I:C0599161
reaction	I:C0599161
and	O
western	B:C0005863
blotting	I:C0005863
.	O

Cratoxylum	B:C1219382
formosum	I:C1219382
induced	O
HepG2	O
cell	O
death	I:C0007587
in	O
a	O
time	O
-	O
and	O
dose	O
-	O
dependent	O
manner	O
with	O
half	O
maximal	O
inhibitory	O
concentration	O
values	O
of	O
219.03±9.96	O
and	O
124.90±6.86	O
µg/	O
ml	O
at	O
24	O
and	O
48	O
h	O
,	O
respectively	O
.	O

Cratoxylum	O
formosum	I:C1219382
induced	O
HepG2	B:C2717940
cell	O
death	I:C0007587
in	O
a	O
time	O
-	O
and	O
dose	O
-	O
dependent	O
manner	O
with	O
half	O
maximal	O
inhibitory	O
concentration	O
values	O
of	O
219.03±9.96	O
and	O
124.90±6.86	O
µg/	O
ml	O
at	O
24	O
and	O
48	O
h	O
,	O
respectively	O
.	O

Cratoxylum	O
formosum	I:C1219382
induced	O
HepG2	O
cell	B:C0007587
death	I:C0007587
in	O
a	O
time	O
-	O
and	O
dose	O
-	O
dependent	O
manner	O
with	O
half	O
maximal	O
inhibitory	O
concentration	O
values	O
of	O
219.03±9.96	O
and	O
124.90±6.86	O
µg/	O
ml	O
at	O
24	O
and	O
48	O
h	O
,	O
respectively	O
.	O

Treatment	B:C0087111
with	O
Cratoxylum	O
formosum	I:C1219382
caused	O
a	O
significant	O
and	O
dose	O
-	O
dependent	O
decrease	O
in	O
colony	O
forming	O
ability	O
and	O
cell	O
migration	I:C1622501
.	O

Treatment	O
with	O
Cratoxylum	B:C1219382
formosum	I:C1219382
caused	O
a	O
significant	O
and	O
dose	O
-	O
dependent	O
decrease	O
in	O
colony	O
forming	O
ability	O
and	O
cell	O
migration	I:C1622501
.	O

Treatment	O
with	O
Cratoxylum	O
formosum	I:C1219382
caused	O
a	O
significant	O
and	O
dose	O
-	O
dependent	O
decrease	O
in	O
colony	O
forming	O
ability	O
and	O
cell	B:C1622501
migration	I:C1622501
.	O

Furthermore	O
,	O
the	O
present	O
study	B:C2603343
demonstrated	O
that	O
Cratoxylum	O
formosum	I:C1219382
induced	O
ROS	O
formation	I:C1148560
,	O
increased	O
caspase	O
3	I:C1150132
activities	I:C1150132
,	O
decreased	O
the	O
ΔΨm	O
,	O
and	O
caused	O
HepG2	O
apoptosis	O
.	O

Furthermore	O
,	O
the	O
present	O
study	O
demonstrated	O
that	O
Cratoxylum	B:C1219382
formosum	I:C1219382
induced	O
ROS	O
formation	I:C1148560
,	O
increased	O
caspase	O
3	I:C1150132
activities	I:C1150132
,	O
decreased	O
the	O
ΔΨm	O
,	O
and	O
caused	O
HepG2	O
apoptosis	O
.	O

Furthermore	O
,	O
the	O
present	O
study	O
demonstrated	O
that	O
Cratoxylum	O
formosum	I:C1219382
induced	O
ROS	B:C1148560
formation	I:C1148560
,	O
increased	O
caspase	O
3	I:C1150132
activities	I:C1150132
,	O
decreased	O
the	O
ΔΨm	O
,	O
and	O
caused	O
HepG2	O
apoptosis	O
.	O

Furthermore	O
,	O
the	O
present	O
study	O
demonstrated	O
that	O
Cratoxylum	O
formosum	I:C1219382
induced	O
ROS	O
formation	I:C1148560
,	O
increased	O
caspase	B:C1150132
3	I:C1150132
activities	I:C1150132
,	O
decreased	O
the	O
ΔΨm	O
,	O
and	O
caused	O
HepG2	O
apoptosis	O
.	O

Furthermore	O
,	O
the	O
present	O
study	O
demonstrated	O
that	O
Cratoxylum	O
formosum	I:C1219382
induced	O
ROS	O
formation	I:C1148560
,	O
increased	O
caspase	O
3	I:C1150132
activities	I:C1150132
,	O
decreased	O
the	O
ΔΨm	B:C1720920
,	O
and	O
caused	O
HepG2	O
apoptosis	O
.	O

Furthermore	O
,	O
the	O
present	O
study	O
demonstrated	O
that	O
Cratoxylum	O
formosum	I:C1219382
induced	O
ROS	O
formation	I:C1148560
,	O
increased	O
caspase	O
3	I:C1150132
activities	I:C1150132
,	O
decreased	O
the	O
ΔΨm	O
,	O
and	O
caused	O
HepG2	B:C2717940
apoptosis	O
.	O

Furthermore	O
,	O
the	O
present	O
study	O
demonstrated	O
that	O
Cratoxylum	O
formosum	I:C1219382
induced	O
ROS	O
formation	I:C1148560
,	O
increased	O
caspase	O
3	I:C1150132
activities	I:C1150132
,	O
decreased	O
the	O
ΔΨm	O
,	O
and	O
caused	O
HepG2	O
apoptosis	B:C0162638
.	O

Cratoxylum	B:C1219382
formosum	I:C1219382
marginally	O
decreased	O
the	O
expression	O
level	O
of	O
the	O
cell	O
cycle	I:C0674679
regulatory	I:C0674679
protein	I:C0674679
,	O
ras-related	O
C3	I:C0139880
botulinum	I:C0139880
toxin	I:C0139880
substrate	I:C0139880
1	I:C0139880
(	O
rho	O
family	O
,	O
small	O
GTP	I:C0139880
binding	I:C0139880
protein	I:C0139880
Rac1	I:C0139880
)	O
and	O
the	O
downstream	O
protein	I:C0033684
,	O
cyclin	O
dependent	I:C0252132
kinase	I:C0252132
6	I:C0252132
.	O

Cratoxylum	O
formosum	I:C1219382
marginally	O
decreased	O
the	O
expression	O
level	O
of	O
the	O
cell	B:C0674679
cycle	I:C0674679
regulatory	I:C0674679
protein	I:C0674679
,	O
ras-related	O
C3	I:C0139880
botulinum	I:C0139880
toxin	I:C0139880
substrate	I:C0139880
1	I:C0139880
(	O
rho	O
family	O
,	O
small	O
GTP	I:C0139880
binding	I:C0139880
protein	I:C0139880
Rac1	I:C0139880
)	O
and	O
the	O
downstream	O
protein	I:C0033684
,	O
cyclin	O
dependent	I:C0252132
kinase	I:C0252132
6	I:C0252132
.	O

Cratoxylum	O
formosum	I:C1219382
marginally	O
decreased	O
the	O
expression	O
level	O
of	O
the	O
cell	O
cycle	I:C0674679
regulatory	I:C0674679
protein	I:C0674679
,	O
ras-related	B:C0139880
C3	I:C0139880
botulinum	I:C0139880
toxin	I:C0139880
substrate	I:C0139880
1	I:C0139880
(	O
rho	O
family	O
,	O
small	O
GTP	I:C0139880
binding	I:C0139880
protein	I:C0139880
Rac1	I:C0139880
)	O
and	O
the	O
downstream	O
protein	I:C0033684
,	O
cyclin	O
dependent	I:C0252132
kinase	I:C0252132
6	I:C0252132
.	O

Cratoxylum	O
formosum	I:C1219382
marginally	O
decreased	O
the	O
expression	O
level	O
of	O
the	O
cell	O
cycle	I:C0674679
regulatory	I:C0674679
protein	I:C0674679
,	O
ras-related	O
C3	I:C0139880
botulinum	I:C0139880
toxin	I:C0139880
substrate	I:C0139880
1	I:C0139880
(	O
rho	O
family	O
,	O
small	B:C0139880
GTP	I:C0139880
binding	I:C0139880
protein	I:C0139880
Rac1	I:C0139880
)	O
and	O
the	O
downstream	O
protein	I:C0033684
,	O
cyclin	O
dependent	I:C0252132
kinase	I:C0252132
6	I:C0252132
.	O

Cratoxylum	O
formosum	I:C1219382
marginally	O
decreased	O
the	O
expression	O
level	O
of	O
the	O
cell	O
cycle	I:C0674679
regulatory	I:C0674679
protein	I:C0674679
,	O
ras-related	O
C3	I:C0139880
botulinum	I:C0139880
toxin	I:C0139880
substrate	I:C0139880
1	I:C0139880
(	O
rho	O
family	O
,	O
small	O
GTP	I:C0139880
binding	I:C0139880
protein	I:C0139880
Rac1	I:C0139880
)	O
and	O
the	O
downstream	B:C0033684
protein	I:C0033684
,	O
cyclin	O
dependent	I:C0252132
kinase	I:C0252132
6	I:C0252132
.	O

Cratoxylum	O
formosum	I:C1219382
marginally	O
decreased	O
the	O
expression	O
level	O
of	O
the	O
cell	O
cycle	I:C0674679
regulatory	I:C0674679
protein	I:C0674679
,	O
ras-related	O
C3	I:C0139880
botulinum	I:C0139880
toxin	I:C0139880
substrate	I:C0139880
1	I:C0139880
(	O
rho	O
family	O
,	O
small	O
GTP	I:C0139880
binding	I:C0139880
protein	I:C0139880
Rac1	I:C0139880
)	O
and	O
the	O
downstream	O
protein	I:C0033684
,	O
cyclin	B:C0252132
dependent	I:C0252132
kinase	I:C0252132
6	I:C0252132
.	O

Additionally	O
,	O
Cratoxylum	B:C1219382
formosum	I:C1219382
significantly	O
enhanced	O
p21	O
levels	O
,	O
reduced	O
cyclin	O
D1	I:C0033684
protein	I:C0033684
levels	O
and	O
triggered	O
cancer	O
cell	O
death	I:C0007587
.	O

Additionally	O
,	O
Cratoxylum	O
formosum	I:C1219382
significantly	O
enhanced	O
p21	B:C0288472
levels	O
,	O
reduced	O
cyclin	O
D1	I:C0033684
protein	I:C0033684
levels	O
and	O
triggered	O
cancer	O
cell	O
death	I:C0007587
.	O

Additionally	O
,	O
Cratoxylum	O
formosum	I:C1219382
significantly	O
enhanced	O
p21	O
levels	O
,	O
reduced	O
cyclin	B:C0033684
D1	I:C0033684
protein	I:C0033684
levels	O
and	O
triggered	O
cancer	O
cell	O
death	I:C0007587
.	O

Additionally	O
,	O
Cratoxylum	O
formosum	I:C1219382
significantly	O
enhanced	O
p21	O
levels	O
,	O
reduced	O
cyclin	O
D1	I:C0033684
protein	I:C0033684
levels	O
and	O
triggered	O
cancer	B:C0006826
cell	O
death	I:C0007587
.	O

Additionally	O
,	O
Cratoxylum	O
formosum	I:C1219382
significantly	O
enhanced	O
p21	O
levels	O
,	O
reduced	O
cyclin	O
D1	I:C0033684
protein	I:C0033684
levels	O
and	O
triggered	O
cancer	O
cell	B:C0007587
death	I:C0007587
.	O

Cratoxylum	B:C1219382
formosum	I:C1219382
leaf	O
extracts	I:C0032081
induced	O
cell	O
death	I:C0007587
,	O
stimulated	O
apoptosis	O
and	O
inhibited	O
migration	O
in	O
HepG2	O
cells	I:C2717940
.	O

Cratoxylum	O
formosum	I:C1219382
leaf	B:C0032081
extracts	I:C0032081
induced	O
cell	O
death	I:C0007587
,	O
stimulated	O
apoptosis	O
and	O
inhibited	O
migration	O
in	O
HepG2	O
cells	I:C2717940
.	O

Cratoxylum	O
formosum	I:C1219382
leaf	O
extracts	I:C0032081
induced	O
cell	B:C0007587
death	I:C0007587
,	O
stimulated	O
apoptosis	O
and	O
inhibited	O
migration	O
in	O
HepG2	O
cells	I:C2717940
.	O

Cratoxylum	O
formosum	I:C1219382
leaf	O
extracts	I:C0032081
induced	O
cell	O
death	I:C0007587
,	O
stimulated	O
apoptosis	B:C0162638
and	O
inhibited	O
migration	O
in	O
HepG2	O
cells	I:C2717940
.	O

Cratoxylum	O
formosum	I:C1219382
leaf	O
extracts	I:C0032081
induced	O
cell	O
death	I:C0007587
,	O
stimulated	O
apoptosis	O
and	O
inhibited	O
migration	B:C1622501
in	O
HepG2	O
cells	I:C2717940
.	O

Cratoxylum	O
formosum	I:C1219382
leaf	O
extracts	I:C0032081
induced	O
cell	O
death	I:C0007587
,	O
stimulated	O
apoptosis	O
and	O
inhibited	O
migration	O
in	O
HepG2	B:C2717940
cells	I:C2717940
.	O

Thus	O
,	O
Cratoxylum	B:C1219382
formosum	I:C1219382
may	O
be	O
useful	O
for	O
developing	O
an	O
anticancer	O
drug	I:C0003392
candidate	I:C0003392
for	O
the	O
treatment	O
of	O
liver	O
cancer	I:C0345904
.	O

Thus	O
,	O
Cratoxylum	O
formosum	I:C1219382
may	O
be	O
useful	O
for	O
developing	O
an	O
anticancer	B:C0003392
drug	I:C0003392
candidate	I:C0003392
for	O
the	O
treatment	O
of	O
liver	O
cancer	I:C0345904
.	O

Thus	O
,	O
Cratoxylum	O
formosum	I:C1219382
may	O
be	O
useful	O
for	O
developing	O
an	O
anticancer	O
drug	I:C0003392
candidate	I:C0003392
for	O
the	O
treatment	B:C0087111
of	O
liver	O
cancer	I:C0345904
.	O

Thus	O
,	O
Cratoxylum	O
formosum	I:C1219382
may	O
be	O
useful	O
for	O
developing	O
an	O
anticancer	O
drug	I:C0003392
candidate	I:C0003392
for	O
the	O
treatment	O
of	O
liver	B:C0345904
cancer	I:C0345904
.	O

